DEPICT enables sample-centric therapeutic prioritization across evolving and spatially heterogeneous tumor states
Accurate treatment selection remains a major challenge in precision oncology because tumors with similar genomic alterations can respond differently to therapy. Most drug-response models evaluate individual drugs or drug-sample pairs, whereas clinical decision-making requires therapies to be prioritized within each tumor context. Here we present DEPICT (Drug Efficacy Prediction via Integrated…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
